Life Technologies Corporation announced its merger with Thermo Fisher Scientific Wednesday. After the Special Meeting of Stockholders earlier, the election resulted in 98% in favor of pushing through with the deal, or about 72% of the company's outstanding shares.

As reported last April 15, 2013, the Board of Directors from Life Technologies endorsed its purchase by Thermo Fisher for USD 76.00 per share in cash. The said amount was subject to an increase if the deal was not closed by January 14, 2014. The said arrangement also remained subjected to the satisfaction of the final provisions laid down in the merger settlement, including regulatory approvals.

Life Technologies Corporation, a global biotechnology company, is devoted to delivering the most modern products and services in the particular fields of scientific research, genetic analysis, including applied sciences. The corporation's portfolio is composed of 5,000 patents and licenses covering the biological field. Life Technologies Corp. currently has 10,000 employees under its management with a sales output of USD 3.8 billion in 2012.